Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Production and Evaluation of In-Vitro and In-Vivo Effects of P28-Il24, a Promising Anti-Breast Cancer Fusion Protein Publisher



Ghavimi R1, 2 ; Akbari V1 ; Jahaniannajafabadi A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Student Research Committee, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Peptide Research and Therapeutics Published:2021


Abstract

Interleukin-24 (IL-24) is known to selectively induce apoptosis in cancer cells through endoplasmic reticulum (ER) stress. However, this protein alone is unable to enter cells and consequently it is not able to inhibit cell proliferation. In this study, we developed a novel recombinant chimeric protein containing IL-24 which is linked to P28, a cancer specific cell-penetrating peptide and P53 stabilizer, to target IL-24 into breast cancer cells. After design, expression and purification of the P28-IL-24 fusion protein and IL-24 as control, specific and non-specific cytolethal effects of this fusion protein were evaluated in-vitro and in-vivo. Cell proliferation assay and cell death mechanism analysis carried out by MTT and flow cytometry, respectively. Afterward, anti-tumor effects of P28-IL-24 in animal model were investigated by hematoxylin and eosin (H&E) staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay, respectively. Results showed inhibitory effects on proliferation of MCF-7 and MDA-MB-231 cancer cells by the P28-IL-24 protein. However, HUVEC cells were affected by the fusion protein just at 1.8 µg/ml concentration. In addition, p28-IL-24 showed to induce apoptosis in the mentioned cell lines. Moreover, treatment of inbred Balb/C mice bearing syngenic 4T1 tumor cells with the p28-IL-24 reduced tumor size within the study period (p < 0.05). H&E staining and TUNEL assay, revealed that this tumor growth suppression was associated with increase in necrotic and apoptotic cells. Taken together, the findings of the current study suggest that the chimeric protein p28-IL-24 can serve as a potent candidate for further preclinical evaluations. © 2021, The Author(s), under exclusive licence to Springer Nature B.V.
Related Docs
View other Related Docs
1. In Silico Design of Two Novel Fusion Proteins, P28-Il-24 and P28-M4, Targeted to Breast Cancer Cells, Research in Pharmaceutical Sciences (2020)
2. Mda-7/Interleukin 24 (Il-24) in Tumor Gene Therapy: Application of Tumor Penetrating/Homing Peptides for Improvement of the Effects, Expert Opinion on Biological Therapy (2019)
3. Application of Antimicrobial Peptides in the Design and Production of Anticancer Agents, International Journal of Peptide Research and Therapeutics (2023)
4. Expression, Purification, and Cytotoxic Evaluation of Il24-Br2 Fusion Protein, Research in Pharmaceutical Sciences (2019)
5. Maximizing the Recovery of the Native P28 Bacterial Peptide With Improved Activity and Maintained Solubility and Stability in Escherichia Coli Bl21 (De3), Journal of Microbiological Methods (2022)
6. Pseudomonas Exotoxin-Based Immunotoxins: Over Three Decades of Efforts on Targeting Cancer Cells With the Toxin, Frontiers in Oncology (2021)
7. Producing Soluble Human Programmed Cell Death Protein-1: A Natural Supporter for Cd4+T Cell Cytotoxicity and Tumor Cells Apoptosis, Iranian Journal of Biotechnology (2019)
8. Optimization of in Vitro Expansion and Activation of Human Natural Killer Cells Against Breast Cancer Cell Line, Avicenna Journal of Medical Biotechnology (2020)
Experts (# of related papers)
View all Related Experts
Ali Jahanian Najafabadi (7)
Fatemeh Shafiee (5)
Other Related Docs
9. Cycloartane Triterpenoid From Euphorbia Macrostegia Modulates Er Stress Signaling Pathways to Induce Apoptosis in Mda-Mb231 and Mcf-7 Breast Cancer Cell Lines, Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
10. In Silico and in Vitro Studies of Cytotoxic Activity of Different Peptides Derived From Vesicular Stomatitis Virus G Protein, Iranian Journal of Basic Medical Sciences (2015)
11. Dff40-Irgd, a Novel Chimeric Protein With Efficient Cytotoxic and Apoptotic Effects Against Triple-Negative Breast Cancer Cells, Biotechnology Letters (2021)
12. A-Ngr Fusion Protein Induces Apoptosis in Human Cancer Cells, EXCLI Journal (2018)
13. Characterization of Antitumor Activity of a Synthetic Moronecidin-Like Peptide Computationally Predicted From the Tiger Tail Seahorse Hippocampus Comes in Tumor-Bearing Mice, International Journal of Peptide Research and Therapeutics (2021)
14. Synergistic Antitumor Effect of Nvp-Bez235 and Cape on Mda-Mb-231 Breast Cancer Cells, Biomedicine and Pharmacotherapy (2017)
15. Immunogenic Cell Death Inducer Peptides: A New Approach for Cancer Therapy, Current Status and Future Perspectives, Biomedicine and Pharmacotherapy (2023)
16. Production and Evaluation of Cytotoxic Effects of Dt386-Br2 Fusion Protein As a Novel Anti-Cancer Agent, Journal of Microbiological Methods (2016)
17. Adenosine A1 Receptor Modifies P53 Expression and Apoptosis in Breast Cancer Cell Line Mcf-7, Bratislava Medical Journal (2016)
18. The Evaluation of Tlyp-1-Bound Mda-7/Il-24 Killing Activity on a Liver Tumor Cell Line, Cancer Biotherapy and Radiopharmaceuticals (2021)
19. The Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 and Caspase 3, 8, and 9 Expression and Apoptosis Rate in Mcf-7 Breast Cancer Cell Line, Research in Pharmaceutical Sciences (2016)
20. Br2, a Buforin Derived Cancer Specific Cell Penetrating Peptide for Targeted Delivering of Toxic Agents: A Review Article, International Journal of Peptide Research and Therapeutics (2022)
21. A Bi-Functional Targeted P28-Nrc Chimeric Protein With Enhanced Cytotoxic Effects on Breast Cancer Cell Lines, Iranian Journal of Pharmaceutical Research (2019)